| Dr Brett Marsh Dolgin, DO | |
|
255 Great Neck Rd Apt Ph15, Great Neck, NY 11021-3358 | |
| (516) 353-7086 | |
| Not Available |
| Full Name | Dr Brett Marsh Dolgin |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 14 Years |
| Location | 255 Great Neck Rd Apt Ph15, Great Neck, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417206459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207NS0135X | Dermatology - Procedural Dermatology | 267986 (New York) | Primary |
| 207Q00000X | Family Medicine | 60267986 (New York) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peter A Klein, Md, Faad, Pc | 3971492455 | 5 |
News Archive
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.
Leading Senate Democrats moved today to repeal a law protecting insurers from antitrust taboos in the wake of an industry-sponsored report that condemned a key reform proposal, the New York Times reports. Testifying before the Judiciary Committee as a witness, Majority Leader Harry Reid, D-Nev., said, "Providing an exemption for insurance companies to antitrust laws has been anticompetitive and damaging to the American economy."
Researchers at the Medical University of South Carolina reported results from a large cross-sectional analysis assessing the risk of colon cancer among patients with diabetes at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
A new study launched today (Thursday 19 November) has revealed key steps for hospitals to improve care for pregnant mums and babies.
› Verified 4 days ago
| Entity Name | Peter A Klein, Md, Faad, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902837396 PECOS PAC ID: 3971492455 Enrollment ID: O20090521000091 |
News Archive
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.
Leading Senate Democrats moved today to repeal a law protecting insurers from antitrust taboos in the wake of an industry-sponsored report that condemned a key reform proposal, the New York Times reports. Testifying before the Judiciary Committee as a witness, Majority Leader Harry Reid, D-Nev., said, "Providing an exemption for insurance companies to antitrust laws has been anticompetitive and damaging to the American economy."
Researchers at the Medical University of South Carolina reported results from a large cross-sectional analysis assessing the risk of colon cancer among patients with diabetes at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
A new study launched today (Thursday 19 November) has revealed key steps for hospitals to improve care for pregnant mums and babies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brett Marsh Dolgin, DO 255 Great Neck Rd Apt Ph15, Great Neck, NY 11021-3358 Ph: (516) 353-7086 | Dr Brett Marsh Dolgin, DO 255 Great Neck Rd Apt Ph15, Great Neck, NY 11021-3358 Ph: (516) 353-7086 |
News Archive
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.
Leading Senate Democrats moved today to repeal a law protecting insurers from antitrust taboos in the wake of an industry-sponsored report that condemned a key reform proposal, the New York Times reports. Testifying before the Judiciary Committee as a witness, Majority Leader Harry Reid, D-Nev., said, "Providing an exemption for insurance companies to antitrust laws has been anticompetitive and damaging to the American economy."
Researchers at the Medical University of South Carolina reported results from a large cross-sectional analysis assessing the risk of colon cancer among patients with diabetes at the 70th Annual Scientific Meeting of the American College of Gastroenterology.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
A new study launched today (Thursday 19 November) has revealed key steps for hospitals to improve care for pregnant mums and babies.
› Verified 4 days ago
Mrs. Angela Azar, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 935 Northern Blvd Ste 106, Great Neck, NY 11021 Phone: 516-482-3496 Fax: 516-482-3497 | |
Dr. Jonathan David Kurt Trager, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 212 Middle Neck Rd, Suite #5, Great Neck, NY 11021 Phone: 516-482-5400 Fax: 516-482-5401 | |
Dr. Joshua Andrew Farhadian, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1000 Northern Blvd Ste 140, Great Neck, NY 11021 Phone: 516-846-3300 Fax: 516-846-3305 | |
Achiamah Osei-tutu, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 560 Northern Blvd, Suite 204a, Great Neck, NY 11021 Phone: 516-506-0025 Fax: 516-506-0032 | |
Dr. Nancy Sue Wolfin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 310 E Shore Rd, 204, Great Neck, NY 11023 Phone: 516-829-4464 Fax: 516-829-0931 | |
Dr. Adam Ben Bodian, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11 Grace Ave, Suite 100 Bodian Dermatology Group Pc, Great Neck, NY 11021 Phone: 516-482-2882 Fax: 516-482-6039 |